ARCHIVES

Olaparib Study Demonstrates No Changes In Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Kushner Forms BreastPac

June 17, 1988

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

Other DCE Contract Recompetitions OKed

November 15, 1985

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994